Correction to: Effectiveness of Messenger RNA-Based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
- PMID: 36857145
- PMCID: PMC10350809
- DOI: 10.1093/cid/ciac810
Correction to: Effectiveness of Messenger RNA-Based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
Erratum for
-
Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.Clin Infect Dis. 2022 Dec 19;75(12):2186-2192. doi: 10.1093/cid/ciac325. Clin Infect Dis. 2022. PMID: 35475889 Free PMC article.